• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺增生症诊断与治疗中的争议

Controversies in the diagnosis and management of benign prostatic hypertrophy.

作者信息

DuBeau C E, Resnick N M

机构信息

Division on Aging, Harvard Medical School, Boston, Massachusetts.

出版信息

Adv Intern Med. 1992;37:55-83.

PMID:1373030
Abstract

The prevalence of BPH ensures a continuing need for internists to be aware of the issues regarding the evaluation and treatment of prostatism, while the developing role of nonoperative therapy and the growing recognition of the importance of patient preferences have opened the way for an expanded involvement of the primary care practitioner in the management of these patients. Prostatism remains a difficult clinical problem since many of the symptoms and diagnostic tests are nonspecific, especially in the elderly. Basic questions regarding the role of bladder outlet obstruction (BOO) in the development of symptoms and in predicting outcome from surgery await further study. Against this background of uncertainty, however, is the reassurance that the natural history of the process results in serious complications in only the minority of patients. Important work is under way that will incorporate quality of life outcomes, compare surgery with "watchful waiting," and randomize patients to surgical and nonsurgical treatments. In the interim, the internist may help patients with prostatism significantly by appreciating the natural history of the condition, treating the conditions that mimic or exacerbate it, understanding the clinical utility and limitations of current evaluation methods, becoming aware of the growing array of nonsurgical and minimal-surgery options, and assisting patients in weighing therapeutic risks and benefits with their concerns about symptoms.

摘要

良性前列腺增生的高发病率使得内科医生持续需要了解有关前列腺增生评估和治疗的问题,而非手术治疗作用的不断发展以及对患者偏好重要性认识的日益提高,为初级保健医生更多地参与这些患者的管理开辟了道路。前列腺增生仍然是一个棘手的临床问题,因为许多症状和诊断测试都不具有特异性,尤其是在老年人中。关于膀胱出口梗阻(BOO)在症状发展和手术预后预测中的作用的基本问题有待进一步研究。然而,在这种不确定性的背景下,令人安心的是,该疾病的自然病程仅在少数患者中导致严重并发症。目前正在进行重要的工作,将纳入生活质量结果,比较手术与“观察等待”,并将患者随机分配到手术和非手术治疗组。在此期间,内科医生可以通过了解病情的自然病程、治疗模仿或加重该病情的疾病、理解当前评估方法的临床效用和局限性、了解越来越多的非手术和微创手术选择以及帮助患者权衡治疗风险和益处以及他们对症状的担忧,来显著帮助患有前列腺增生的患者。

相似文献

1
Controversies in the diagnosis and management of benign prostatic hypertrophy.良性前列腺增生症诊断与治疗中的争议
Adv Intern Med. 1992;37:55-83.
2
Benign prostatic hyperplasia: a review.良性前列腺增生:综述
Can J Urol. 2000 Dec;7(6):1135-43.
3
The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?美国泌尿外科学会症状评分在评估男性下尿路症状中的应用:随访2年,其是否有效?
J Urol. 1996 Jun;155(6):1971-4.
4
An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.一项亚洲多国针对良性前列腺增生患者的前瞻性观察性登记研究,重点关注合并症、下尿路症状和性功能。
BJU Int. 2008 Jan;101(2):197-202. doi: 10.1111/j.1464-410X.2007.07320.x. Epub 2007 Nov 13.
5
Managing patients with benign prostatic hyperplasia.
Am Fam Physician. 1995 Jul;52(1):135-42, 145-6.
6
Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.良性前列腺增生:诊断与治疗。医疗保健政策与研究机构。
Clin Pract Guidel Quick Ref Guide Clin. 1994 Feb(8):1-17.
7
Invasively estimated International Continence Society obstruction classification versus noninvasively assessed bladder outlet obstruction probability in treatment recommendation for LUTS suggestive of BPH.在提示良性前列腺增生的下尿路症状治疗推荐中,有创评估的国际尿控协会梗阻分级与无创评估的膀胱出口梗阻可能性的比较
Urology. 2007 Mar;69(3):485-90. doi: 10.1016/j.urology.2006.10.039.
8
An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.良性前列腺增生症治疗的经济成本及与患者相关后果的评估。
BJU Int. 2006 May;97(5):1007-16. doi: 10.1111/j.1464-410X.2005.06089.x. Epub 2006 Mar 17.
9
Urodynamic and clinical effects of noninvasive and minimally invasive treatments in elderly men with lower urinary tract symptoms stratified according to the grade of obstruction.根据梗阻程度分层的老年男性下尿路症状的无创和微创治疗的尿动力学及临床效果
Urology. 1997 Jul;50(1):55-61. doi: 10.1016/S0090-4295(97)00112-X.
10
Benign prostatic hyperplasia in older men.
Clin Geriatr Med. 1998 May;14(2):317-31.

引用本文的文献

1
Evaluation of the Antioxidant and Antiangiogenic Activity of a Pomegranate Extract in BPH-1 Prostate Epithelial Cells.评价石榴提取物对 BPH-1 前列腺上皮细胞的抗氧化和抗血管生成活性。
Int J Mol Sci. 2023 Jun 27;24(13):10719. doi: 10.3390/ijms241310719.
2
6-sialyllactose ameliorates dihydrotestosterone-induced benign prostatic hyperplasia through suppressing VEGF-mediated angiogenesis.6-唾液酸乳糖通过抑制 VEGF 介导的血管生成改善二氢睾酮诱导的良性前列腺增生。
BMB Rep. 2019 Sep;52(9):560-565. doi: 10.5483/BMBRep.2019.52.9.113.
3
A herbal formula, comprising and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats.
一种包含[具体成分]和蜂花粉的草药配方可抑制雄性Wistar大鼠中睾酮诱导的良性前列腺增生的发展。
Saudi J Biol Sci. 2017 Nov;24(7):1555-1561. doi: 10.1016/j.sjbs.2015.10.020. Epub 2015 Nov 6.
4
Influence of Panax ginseng on Alpha-Adrenergic Receptor of Benign Prostatic Hyperplasia.人参对良性前列腺增生症α-肾上腺素能受体的影响。
Int Neurourol J. 2014 Dec;18(4):179-86. doi: 10.5213/inj.2014.18.4.179. Epub 2014 Dec 29.